ON ON shares rise 239 percent post Q4 2025 earnings despite slight EPS miss and 153 percent yearoveryear revenue drop LU Lufax posts steep Q3 2024 earnings miss and doubledigit yearoveryear revenue drop even as shares rise modestly Southern Company SO Recent ShortTerm Price Underperformance Valuation Metrics and Upcoming Earnings Preview KalVista Pharmaceuticals KALV Stock Fundamentals Q4 2025 EPS Tops Views